Trials / Unknown
UnknownNCT05012137
The MEV of 0.5% Ropivacaine in Ultrasound-guided SASIS-FICB
The Minimum Effective Volume (MEV) of 0.5% Ropivacaine in Ultrasound-guided Supra-anterior Superior Iliac Spine Fascia Iliaca Compartment Block (SASIS-FICB)
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 54 (estimated)
- Sponsor
- Peking Union Medical College Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The Aim of This Study is to Determine the Minimum Effective Volume of Local Anesthetic (Ropivacaine 0.5%) Required to Produce an Effective Ultrasound-guided Supra-anterior Superior Iliac Spine Fascia Iliaca Compartment Block(SASIS-FICB) for Surgical Anesthesia in 90% of Patients Scheduled for Elective Surgery of One Lower Limbs.
Detailed description
The study is based on biased coin design, and the volume of Local Anesthetic (Ropivacaine 0.5%) for the next patient is determined by the result of the last one. In the case of block failure, the volume will be increased by 2.5ml. Conversely, block success will result in either a reduction in volume by 2.5ml (probability 11%) or no change in volume (probability 89%). A blinded assistant will assess sensory and motor blockade in each nerve territory ( the femoral, obturator and lateral femoral cutaneous nerves) at 5-min intervals up to 30 min after completion of the block. Finally, MEV90 is calculated by isotonic regression.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Ultrasound-guided Supra-anterior Superior Iliac Spine Fascia Iliaca Compartment Block (SASIS-FICB) with 0.5% ropivacaine | all the patients received Ultrasound-guided Supra-anterior Superior Iliac Spine Fascia Iliaca Compartment Block (SASIS-FICB) |
| DRUG | different volume of 0.5% ropivacaine | According to the subject's response to the injection dose, the next subject will be injected with a different volume of the drug according to the preset rules |
Timeline
- Start date
- 2021-08-25
- Primary completion
- 2021-10-25
- Completion
- 2021-11-25
- First posted
- 2021-08-19
- Last updated
- 2021-08-27
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05012137. Inclusion in this directory is not an endorsement.